PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy
Status:
Completed
Trial end date:
2013-03-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the treatment effect of panitumumab in combination
with FOLFOX compared to FOLFOX alone as first line therapy for metastatic colorectal cancer